Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis

Author:

Henderson Alasdair D,Butler-Cole Ben FC,Tazare John,Tomlinson Laurie A,Marks Michael,Jit Mark,Briggs Andrew,Lin Liang-Yu,Carlile Oliver,Bates Chris,Parry John,Bacon Sebastian CJ,Dillingham Iain,Dennison William A,Costello Ruth E,Wei Yinghui,Walker Alex J,Hulme William,Goldacre Ben,Mehrkar Amir,MacKenna Brian,Herrett Emily,Eggo Rosalind M,

Abstract

AbstractBackgroundLong COVID is the patient-coined term for the persistent symptoms of COVID-19 illness for weeks, months or years following the acute infection. There is a large burden of long COVID globally from self-reported data, but the epidemiology, causes and treatments remain poorly understood. Primary care is used to help identify and treat patients with long COVID and therefore Electronic Health Records (EHRs) of past COVID-19 patients could be used to help fill these knowledge gaps. We aimed to describe those with long COVID in primary care records in England.MethodsWith the approval of NHS England we used routine clinical data from over 19 million adults in England linked to SARS-COV-2 test result, hospitalisation and vaccination data to describe trends in the recording of 16 clinical codes related to long COVID between November 2020 and January 2023. We calculated rates per 100,000 person-years and plotted how these changed over time. We compared crude and minimally adjusted rates of recorded long COVID in patient records between different key demographic and vaccination characteristics using negative binomial models.FindingsWe identified a total of 55,465 people recorded to have long COVID over the study period, with incidence of new long COVID records increasing steadily over 2021, and declining over 2022. The overall rate per 100,000 person-years was 177.5 cases in women (95% CI: 175.5-179) and 100.5 men (99.5-102). In terms of vaccination against COVID-19, the lowest rates were observed in those with 3+ vaccine doses (103.5 [95% CI: 101.5-105]). Finally, the majority of those with a long COVID record did not have a recorded positive SARS-COV-2 test 12 weeks before the long COVID record.InterpretationEHR recorded long COVID remains very low compared and incident records of long COVID declined over 2022. We found the lowest rates of recorded long COVID in people with 3 or more vaccine doses. We summarised several sources of possible bias for researchers using EHRs to study long COVID.

Publisher

Cold Spring Harbor Laboratory

Reference83 articles.

1. Davis HE , McCorkell L , Vogel JM , Topol EJ . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023 Jan 13;1–14.

2. Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort

3. Why we need a deeper understanding of the pathophysiology of long COVID;Lancet Infect Dis,2023

4. Altmann DM , Whettlock EM , Liu S , Arachchillage DJ , Boyton RJ . The immunology of long COVID. Nat Rev Immunol. 2023 Jul 11;1–17.

5. Innate immune cell activation causes lung fibrosis in a humanized model of long COVID

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3